← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 3,231

Funds Holding Change +18

Funds Holding Growth +0.6%

Value $590B

Holding in Top 10 487

Top 10 Change -195

Top 10 Growth -29%

Value Growth -0.6%

New 166

Increased 1,358

Reduced 1,495

Closed 104

Capital Inflow $17.5B

Capital Outflow $25.3B

Net Capital Flow -$7.82B

Capital Flow Change -$10.5B

Calls $6.17B

Puts $6.78B

Net Calls -$612M

Put/Call Ratio 1.1